ArticleLeukemia2015

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.

L Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.